PRODUCT
With years of hands-on experience working with global leading clients, MicroMED has successfully transformed our innovative MEMS-enabled actuation technology into fully developed drug injection/infusion products. These products address emerging trends and unmet needs in subcutaneous and specialized drug delivery applications. They offer gentle, consistent, and powerful performance based on simple electrochemical principles and efficient energy transfer. The system enables precise control of flow rate and dose through linear or nonlinear actuation. Furthermore, the design is flexible and scalable, accommodating a wide range of dose volumes and viscosities. Additionally, it is both reusable and recyclable, while also capable of integrating connectivity features, allowing it to meet emerging sustainability and digitization/AI trends.
dBOBi OBI
The dBOBi™ on-body injector offers a platform approach to meet biologics product requirements and patient needs
-
Wide range of bag volumes: 10, 20, 25, 50, 60 mL
-
Ultra thin profile and light weight
-
Low cost
Dual-bag OBI – test results of 50mL delivery of solutions (1 & 10 cP) based on three different needle gauges.
Primary Actuator®
ISO 13485-certified/certifying product
Preclinical Micropump
PM-160 Series
PM-500 Series
We have conducted a long-term implant safety test in 5 SPF rats at Mackay Hospital Biomedical Center. Below is a summary for this safety test result:
[Observation]
-
2 rats with hemorrhage on day 1 and recovered after day 4
-
No weight loss for all 5 rats
-
Tissue recovered well for all 5 rats after Day 5
-
Clip gives better heal than Suture
-
No rat shows significant effect and maintain good mobility during the whole testing period
[Method]
-
Implant for 7 days
-
Suture/clip site photo daily
-
Device explanted after 7 days
